Ling-yun Wu

Shanghai, 200233, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Clinical Characteristics and Prognosis Analysis of MDS-RS Patients with Wild-Type SF3B1

Clinical Characteristics and Prognosis Analysis of MDS-RS Patients with Wild-Type SF3B1

Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 02, 2026

Deficiency of Setd2 in mesenchymal stem cells facilitates the progression of myelodysplastic syndrome to leukemia.

Deficiency of Setd2 in mesenchymal stem cells facilitates the progression of myelodysplastic syndrome to leukemia.

Journal: Molecular medicine (Cambridge, Mass.)
Published: July 16, 2025

ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

Journal: Science advances
Published: November 29, 2023

The bcl6 corepressor mutation regulates the progression and transformation of myelodysplastic syndromes by repressing the autophagy flux.

The bcl6 corepressor mutation regulates the progression and transformation of myelodysplastic syndromes by repressing the autophagy flux.

Journal: The international journal of biochemistry & cell biology
Published: February 08, 2023

The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment.

The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment.

Journal: Blood
Published: January 03, 2023

Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia.

Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia.

Journal: Cell research
Published: March 09, 2022

Somatic mutations in SF3B1 aberrant-negative MDS-RS most commonly involved in TP53 genes.

Somatic mutations in SF3B1 aberrant-negative MDS-RS most commonly involved in TP53 genes.

Journal: Journal of cellular and molecular medicine
Published: January 27, 2022

Effect of U2AF1 Mutation to Inflammatory Cytokine Expression in SKM-1 Cells through FOXO3a-Bim Signaling Pathway

Effect of U2AF1 Mutation to Inflammatory Cytokine Expression in SKM-1 Cells through FOXO3a-Bim Signaling Pathway

Journal: Zhongguo shi yan xue ye xue za zhi
Published: December 11, 2021

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.

Journal: Clinical epigenetics
Published: June 07, 2021

Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome.

Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome.

Journal: Frontiers in oncology
Published: September 26, 2020

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations.

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations.

Journal: Scientific reports
Published: July 15, 2019

Anti-Tumor Effect of Rigosertib on HEL and K562 Cells and Its Related Mechanism

Anti-Tumor Effect of Rigosertib on HEL and K562 Cells and Its Related Mechanism

Journal: Zhongguo shi yan xue ye xue za zhi
Published: October 27, 2017
Showing 1-12 of 32

Last Updated: 09/26/2026